FutureCure Health: Financial Breakdown
Decoding financial health metrics of FutureCure Health
Total Revenue₹1.7 Cr125%Prev. FY
Total Expenses₹63.8 Lakh114%Prev. FY
Profit After Tax₹83.5 Lakh122%Prev. FY
Total Assets₹89.2 Cr176%Prev. FY
Net Profit Margin48.3%-2%Prev. FY
FAQs on Financials of FutureCure Health
No. In FY25, FutureCure Health reported a net loss of ₹12.2 Cr, so it was not profitable.
FutureCure Health's revenue declined 6.2% year-on-year, from ₹18.5 Cr in FY24 to ₹17.3 Cr in FY25.
FutureCure Health's estimated EBITDA for FY25 was ₹-8.2 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, FutureCure Health posted revenue of ₹17.3 Cr (down 6.2% YoY) and a net loss of ₹12.2 Cr. Explore the full financials of FutureCure Health here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links